Skip to main content
2241 search results for:

Dapagliflozin 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | Dapagliflozin | News

    Dapagliflozin

    Fournier's gangrene
  2. 01-04-2024 | Dapagliflozin | News

    Dapagliflozin

    Fournier's Gangrene
  3. 01-04-2024 | Dapagliflozin | News

    Dapagliflozin

    Diabetic ketoacidosis
  4. 18-04-2024 | Dapagliflozin | ReviewPaper

    Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review

    In the late 90s, sodium-glucose cotransporter type 2 (SGLT2) inhibitors were developed as non-insulin-dependent antidiabetic drugs, and were eventually approved by the Food and Drug Administration and the European Medicines Agency between 2012 and …

  5. 01-04-2024 | Dapagliflozin | News

    Dapagliflozin

    Euglycemic diabetic-ketoacidosis
  6. 01-03-2024 | Dapagliflozin | News

    Dapagliflozin

    Euglycaemic diabetic ketoacidosis
  7. 01-03-2024 | Metformin | News

    Dapagliflozin/metformin

    Metformin-associated lactic acidosis and acute kidney injury stage III following unintentional drug overdose
  8. 01-03-2024 | Ketoacidosis | News

    Dapagliflozin

    Euglycemic diabetic ketoacidosis
  9. Open Access 03-04-2024 | Dapagliflozin | Online First

    Dapagliflozin and atrial fibrillation: elevated dosing to achieve class I antiarrhythmic effects?

  10. Open Access 14-12-2023 | Dapagliflozin | OriginalPaper

    Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex

    Sodium-glucose cotransporter type 2 (SGLT2) inhibitors reduce the risk of progressive kidney disease and cardiovascular events in patients with chronic kidney disease (CKD). In the DAPA-CKD trial, 1 dapagliflozin reduced the risks of progressive …

  11. 01-02-2024 | Dapagliflozin | News

    Dapagliflozin

    Hypernatraemia
  12. 01-02-2024 | Dapagliflozin | News

    Dapagliflozin

    Euglycaemic diabetic ketoacidosis
  13. 06-02-2024 | Atrial Fibrillation | EditorialNotes

    Dapagliflozin for Atrial Fibrillation

  14. 01-02-2024 | Dapagliflozin | News

    Dapagliflozin/sodium-bicarbonate

    Euglycemic diabetic ketoacidosis and hypokalaemia
  15. 18-03-2024 | Dapagliflozin | Online First

    Additional renoprotective effect of the SGLT2 inhibitor dapagliflozin in a patient with ADPKD receiving tolvaptan treatment

    Autosomal dominant polycystic kidney disease (ADPKD) is a major cause of end-stage kidney disease (ESKD). Vasopressin plays a pivotal role in ADPKD progression; therefore, the selective vasopressin V2 receptor antagonist tolvaptan is used as a key …

  16. Open Access 18-04-2024 | Dapagliflozin | Online First

    Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis

    Type 2 diabetes (T2D) is a chronic metabolic disorder characterized by insulin resistance and eventual functional failure of pancreatic beta cells [ 1 ]. Over the last few decades, the prevalence of T2D has increased globally, rising from 3.9 to …

  17. 27-02-2024 | Dapagliflozin | OriginalPaper

    Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea

    Heart failure (HF) represents a clinical syndrome characterized by pulmonary or systemic congestion due to cardiac structural or functional abnormalities [ 1 ]. It carries a substantial clinical burden, with high prevalence, mortality, and …

  18. Open Access 01-12-2024 | Peritoneal Dialysis | OriginalPaper

    Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function

    Dapagliflozin in this Peritoneal dialysis patients did not show a statistically significant reduction in glucose absorption across the peritoneal membrane. A small increase in the one-hour Sodium dip was noted after one month of Dapagliflozin

  19. Open Access 01-12-2024 | Dapagliflozin | OriginalPaper

    Dapagliflozin improves podocytes injury in diabetic nephropathy via regulating cholesterol balance through KLF5 targeting the ABCA1 signalling pathway

    Diabetic nephropathy (DN), one of the more prevalent microvascular complications in patients diagnosed with diabetes mellitus, is attributed as the main cause of end-stage renal disease (ESRD). Lipotoxicity in podocytes caused by hyperglycemia has …

  20. 01-01-2024 | Dapagliflozin | News

    Dapagliflozin/mycophenolate-mofetil/prednisone

    Prostate abscess and Klebsiella pneumoniae infection

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.